MODIFICATION OF SEROCARD RUBELLA IGG TEST— 510(k) K902571
Substantially EquivalentDisease Detection International, Inc.
FDA 510(k) clearance K902571 for MODIFICATION OF SEROCARD RUBELLA IGG TEST, Substantially Equivalent on 1990-09-05. Applicant: Disease Detection International, Inc.. Device class: 2.
Clearance details
- Applicant
- Disease Detection International, Inc.
- Product code
- Code LFX
- Device class
- Class 2
- Regulation
- 21 CFR 866.3510
- Advisory panel
- Microbiology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Irvine, CA, US
Recent devices under product code LFX
view allMore clearances from Disease Detection International, Inc.
view allData sourced from openFDA. This site is unofficial and independent of the FDA.